• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症患者对 COVID-19 疫苗的认知:一项单机构调查。

Perceptions of the COVID-19 vaccine among patients with cancer: a single-institution survey.

机构信息

Department of Hematology-Oncology, Hotel-Dieu de France University Hospital, Saint Joseph University, Beirut, Lebanon.

出版信息

Future Oncol. 2021 Nov;17(31):4071-4079. doi: 10.2217/fon-2021-0265. Epub 2021 Aug 2.

DOI:10.2217/fon-2021-0265
PMID:34337969
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8328088/
Abstract

This paper reports the results of a survey assessing the acceptance of the COVID-19 vaccine among patients with cancer. In total, 111 adult patients with cancer from a single institution were asked to complete a questionnaire designed to assess their knowledge about the vaccine, their readiness to be vaccinated and the determinants of their decision. 61.3% of the patients considered themselves more vulnerable to COVID-19 than the general population. Television, radio and newspapers were the major sources of information about the vaccine. A total of 55% of the patients were ready to be vaccinated and 14.4% refused the vaccine. The main reason for refusal was incompatibility with patients' disease or treatment. Most of the patients in this institutional sample accepted the COVID-19 vaccine. Better communication of information with patients is needed to decrease vaccine hesitancy.

摘要

这篇论文报告了一项评估癌症患者对 COVID-19 疫苗接受程度的调查结果。总共,来自一家机构的 111 名成年癌症患者被要求完成一份问卷,旨在评估他们对疫苗的了解程度、接种意愿以及决策的决定因素。61.3%的患者认为自己比一般人群更容易感染 COVID-19。电视、广播和报纸是疫苗信息的主要来源。总共 55%的患者准备接种疫苗,而 14.4%的患者拒绝接种疫苗。拒绝接种的主要原因是与患者疾病或治疗不兼容。在这个机构样本中,大多数患者接受了 COVID-19 疫苗。需要与患者更好地沟通信息,以减少疫苗犹豫。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b6c/8328088/787918c91c9c/figure4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b6c/8328088/47c977f6aa64/figure1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b6c/8328088/1cc82bb099f0/figure2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b6c/8328088/a1f0b9cebc23/figure3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b6c/8328088/787918c91c9c/figure4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b6c/8328088/47c977f6aa64/figure1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b6c/8328088/1cc82bb099f0/figure2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b6c/8328088/a1f0b9cebc23/figure3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b6c/8328088/787918c91c9c/figure4.jpg

相似文献

1
Perceptions of the COVID-19 vaccine among patients with cancer: a single-institution survey.癌症患者对 COVID-19 疫苗的认知:一项单机构调查。
Future Oncol. 2021 Nov;17(31):4071-4079. doi: 10.2217/fon-2021-0265. Epub 2021 Aug 2.
2
Impact of corona-phobia on attitudes and acceptance towards COVID-19 vaccine among cancer patients: a single-center study.恐冠症对癌症患者对 COVID-19 疫苗的态度和接受程度的影响:一项单中心研究。
Future Oncol. 2022 Feb;18(4):457-469. doi: 10.2217/fon-2021-1015. Epub 2021 Dec 1.
3
COVID-19 vaccine hesitancy and resistance: Correlates in a nationally representative longitudinal survey of the Australian population.COVID-19 疫苗犹豫和抵制:澳大利亚全国代表性纵向调查中的相关因素。
PLoS One. 2021 Mar 24;16(3):e0248892. doi: 10.1371/journal.pone.0248892. eCollection 2021.
4
High but slightly declining COVID-19 vaccine acceptance and reasons for vaccine acceptance, Finland April to December 2020.2020 年 4 月至 12 月芬兰:高但略有下降的 COVID-19 疫苗接受率及其原因。
Epidemiol Infect. 2021 May 11;149:e123. doi: 10.1017/S0950268821001114.
5
Public awareness about coronavirus vaccine, vaccine acceptance, and hesitancy.公众对冠状病毒疫苗的认知、疫苗接受度和犹豫情况。
J Med Virol. 2021 Dec;93(12):6535-6543. doi: 10.1002/jmv.27199. Epub 2021 Jul 20.
6
Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom.爱尔兰和英国与新冠疫苗犹豫及抵触相关的心理特征。
Nat Commun. 2021 Jan 4;12(1):29. doi: 10.1038/s41467-020-20226-9.
7
COVID-19 vaccine hesitancy in patients with systemic autoimmune rheumatic disease: an interview-based survey.COVID-19 疫苗犹豫在系统性自身免疫性风湿病患者中的研究:一项基于访谈的调查。
Rheumatol Int. 2021 Sep;41(9):1601-1605. doi: 10.1007/s00296-021-04938-9. Epub 2021 Jul 2.
8
COVID-19 vaccine hesitancy and refusal and associated factors in an adult population in Saskatchewan, Canada: Evidence from predictive modelling.加拿大萨斯喀彻温省成年人中对 COVID-19 疫苗的犹豫和拒绝及其相关因素:预测模型的证据。
PLoS One. 2021 Nov 12;16(11):e0259513. doi: 10.1371/journal.pone.0259513. eCollection 2021.
9
Willingness to get the COVID-19 vaccine among patients with rheumatic diseases, healthcare workers and general population in Turkey: a web-based survey.土耳其风湿病患者、医护人员和一般人群对 COVID-19 疫苗的接种意愿:一项基于网络的调查。
Rheumatol Int. 2021 Jun;41(6):1105-1114. doi: 10.1007/s00296-021-04841-3. Epub 2021 Mar 29.
10
Vaccine hesitancy: Beliefs and barriers associated with COVID-19 vaccination among Egyptian medical students.疫苗犹豫:埃及医学生对 COVID-19 疫苗接种的信念和障碍。
J Med Virol. 2021 Jul;93(7):4280-4291. doi: 10.1002/jmv.26910. Epub 2021 Mar 25.

引用本文的文献

1
Capacity building and community of practice for women community health workers in low-resource settings: long-term evaluation of the Mobile University For Health (MUH).资源匮乏地区女性社区卫生工作者的能力建设与实践社群:移动健康大学(MUH)的长期评估
Front Glob Womens Health. 2024 May 20;5:1304954. doi: 10.3389/fgwh.2024.1304954. eCollection 2024.
2
Prospective Observational Study of COVID-19 Vaccination in Patients with Thoracic Malignancies: Adverse Events, Breakthrough Infections and Survival Outcomes.胸部恶性肿瘤患者新冠病毒疫苗接种的前瞻性观察研究:不良事件、突破性感染和生存结果
Biomedicines. 2024 Feb 27;12(3):535. doi: 10.3390/biomedicines12030535.
3

本文引用的文献

1
The ESMO Call to Action on COVID-19 vaccinations and patients with cancer: Vaccinate. Monitor. Educate.欧洲肿瘤内科学会关于新冠病毒疫苗接种与癌症患者的行动呼吁:接种疫苗。进行监测。开展教育。
Ann Oncol. 2021 May;32(5):579-581. doi: 10.1016/j.annonc.2021.01.068. Epub 2021 Feb 12.
2
Electrochemical sensing: A prognostic tool in the fight against COVID-19.电化学传感:抗击新冠疫情的一种预后工具。
Trends Analyt Chem. 2021 Mar;136:116198. doi: 10.1016/j.trac.2021.116198. Epub 2021 Jan 23.
3
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
Cross-sectional survey evaluating the psychological impact of the COVID-19 vaccination campaign in patients with cancer: The VACCINATE study.
横断面调查评估癌症患者中 COVID-19 疫苗接种运动的心理影响:VACCINATE 研究。
PLoS One. 2024 Jan 25;19(1):e0290792. doi: 10.1371/journal.pone.0290792. eCollection 2024.
4
Identifying modifiable factors associated with COVID-19 vaccine hesitancy and acceptance among cancer patients in Jordan.确定约旦癌症患者中与新冠疫苗犹豫和接受度相关的可改变因素。
Front Oncol. 2023 Nov 28;13:1281994. doi: 10.3389/fonc.2023.1281994. eCollection 2023.
5
Factors associated with COVID-19 vaccination coverage in hypertensive patients with Omicron infection in Shanghai, China.与中国上海奥密克戎感染的高血压患者 COVID-19 疫苗接种率相关的因素。
Hum Vaccin Immunother. 2023 Aug;19(2):2253599. doi: 10.1080/21645515.2023.2253599. Epub 2023 Oct 31.
6
Hesitancy toward vaccination against COVID-19: A scoping review of prevalence and associated factors in the Arab world.对 COVID-19 疫苗接种犹豫不决:阿拉伯世界的流行率及相关因素的范围综述。
Hum Vaccin Immunother. 2023 Aug 1;19(2):2245720. doi: 10.1080/21645515.2023.2245720.
7
Determinants of influenza and COVID-19 vaccine intent or uptake in Lebanon: a scoping review of the literature.黎巴嫩流感和 COVID-19 疫苗接种意愿或接种率的决定因素:文献综述。
BMC Infect Dis. 2023 Aug 6;23(1):511. doi: 10.1186/s12879-023-08478-4.
8
Safety and Immunogenicity of Homologous and Heterologous Adenoviral-Vectored and mRNA COVID-19 Vaccine Regimens in Radiotherapy Patients.同源和异源腺病毒载体及mRNA新冠疫苗接种方案在放疗患者中的安全性和免疫原性
Vaccines (Basel). 2023 Jun 23;11(7):1135. doi: 10.3390/vaccines11071135.
9
Insights into the Impact of Hesitancy on Cancer Care and COVID-19.对犹豫心理对癌症护理及新冠疫情影响的洞察
Cancers (Basel). 2023 Jun 8;15(12):3115. doi: 10.3390/cancers15123115.
10
Determinants of COVID-19 immunisation uptake in a country with high mortality and a low vaccination rate.高死亡率和低疫苗接种率国家 COVID-19 免疫接种率的决定因素。
J Infect Public Health. 2023 Aug;16(8):1322-1331. doi: 10.1016/j.jiph.2023.06.001. Epub 2023 Jun 3.
mRNA-1273 新型冠状病毒疫苗的有效性和安全性。
N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30.
4
Priority COVID-19 Vaccination for Patients with Cancer while Vaccine Supply Is Limited.在疫苗供应有限的情况下,优先为癌症患者接种 COVID-19 疫苗。
Cancer Discov. 2021 Feb;11(2):233-236. doi: 10.1158/2159-8290.CD-20-1817. Epub 2020 Dec 19.
5
Understanding COVID-19 vaccine demand and hesitancy: A nationwide online survey in China.了解 COVID-19 疫苗需求和犹豫:中国全国范围内的在线调查。
PLoS Negl Trop Dis. 2020 Dec 17;14(12):e0008961. doi: 10.1371/journal.pntd.0008961. eCollection 2020 Dec.
6
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
7
Willingness to get the COVID-19 vaccine with and without emergency use authorization.对有和没有紧急使用授权的 COVID-19 疫苗的接种意愿。
Am J Infect Control. 2021 Feb;49(2):137-142. doi: 10.1016/j.ajic.2020.11.018. Epub 2020 Nov 20.
8
COVID-19 and Vaccine Hesitancy: A Challenge the United States Must Overcome.新冠疫情与疫苗犹豫:美国必须克服的一项挑战。
J Ambul Care Manage. 2021 Jan/Mar;44(1):71-75. doi: 10.1097/JAC.0000000000000360.
9
COVID-19 vaccine BNT162b1 elicits human antibody and T1 T cell responses.COVID-19 疫苗 BNT162b1 可引发人体抗体和 T1 T 细胞应答。
Nature. 2020 Oct;586(7830):594-599. doi: 10.1038/s41586-020-2814-7. Epub 2020 Sep 30.
10
Attitudes Toward a Potential SARS-CoV-2 Vaccine : A Survey of U.S. Adults.对潜在 SARS-CoV-2 疫苗的态度:对美国成年人的调查。
Ann Intern Med. 2020 Dec 15;173(12):964-973. doi: 10.7326/M20-3569. Epub 2020 Sep 4.